{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:21:41Z","timestamp":1735276901858,"version":"3.32.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109214","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T08:57:44Z","timestamp":1731488264000},"page":"109214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimizing therapeutic enoxaparin in preterm neonates and infants"],"prefix":"10.1016","volume":"245","author":[{"given":"Madeline","family":"Abbott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bustin O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsie","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Thom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2024.109214_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0377-1237(17)30571-3","article-title":"Low molecular weight heparins","volume":"54","author":"Sharma","year":"1998","journal-title":"Med. J. Armed Forces India"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2024.109214_bb0010","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.thromres.2024.109214_bb0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1592\/phco.27.9.1263","article-title":"Enoxaparin use in the neonatal intensive care unit: experience over 8 years","volume":"27","author":"Malowany","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.thromres.2024.109214_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.thromres.2007.11.009","article-title":"Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates","volume":"122","author":"Malowany","year":"2008","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2024.109214_bb0025","doi-asserted-by":"crossref","first-page":"F365","DOI":"10.1136\/fn.88.5.F365","article-title":"Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients","volume":"88","author":"Streif","year":"2003","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"10","key":"10.1016\/j.thromres.2024.109214_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/jp.2015.84","article-title":"Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates","volume":"35","author":"Goldsmith","year":"2015","journal-title":"J. Perinatol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109214_bb0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1076029613480557","article-title":"Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study","volume":"19","author":"Chander","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.thromres.2024.109214_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000537797","article-title":"Evaluation of initial enoxaparin dosing and antifactor Xa levels in infants admitted to the neonatal intensive care unit","volume":"9","author":"Nagy","year":"2024","journal-title":"Biomed Hub."},{"issue":"1","key":"10.1016\/j.thromres.2024.109214_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00043426-199021000-00019","article-title":"Development of the hemostatic system in the neonate and young infant","volume":"12","author":"Andrew","year":"1990","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109214_bb0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V72.5.1651.1651","article-title":"Development of the human coagulation system in the healthy premature infant","volume":"72","author":"Andrew","year":"1988","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2024.109214_bb0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2004-0178","article-title":"Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant","volume":"114","author":"Michaels","year":"2004","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.thromres.2024.109214_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0039-1698456","article-title":"Evaluation of the efficacy of enoxaparin in the neonatal intensive care unit","volume":"38","author":"Song","year":"2021","journal-title":"Am. J. Perinatol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109214_bb0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/jp.2016.218","article-title":"Treatment and follow-up of venous thrombosis in the neonatal intensive care unit: a retrospective study","volume":"37","author":"Bohnhoff","year":"2017","journal-title":"J. Perinatol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109214_bb0070","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1076029613480557","article-title":"Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study","volume":"19","author":"Chander","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109214_bb0075","first-page":"119","article-title":"Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients","volume":"15","author":"Fung","year":"2010","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.thromres.2024.109214_bb0080","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.109214_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231205279","article-title":"Antithrombin therapy: current state and future outlook","volume":"29","author":"Rodgers","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.thromres.2024.109214_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.mph.0000139453.22338.d9","article-title":"An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review","volume":"26","author":"Ho","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109214_bb0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"Clark","year":"2022","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:02Z","timestamp":1735237982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"alternative-id":["S0049384824003463"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109214","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing therapeutic enoxaparin in preterm neonates and infants","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109214"}}